Genzyme Corporation v. Sarepta Therapeutics, Inc.
1:24-cv-00882
Overview
Parties
Defendant
Sarepta Therapeutics Three, LLC Operating Company
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Sarepta Therapeutics, Inc. Operating Company
Represented By
7 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
Genzyme Corporation NPE (Individual / Inventor)
Represented By
11 Attorneys ListedWilks Law, LLC
4250 Lancaster Pike, Suite 200
Wilks Law, LLC
4250 Lancaster Pike, Ste 200
Wilks Law, LLC
4250 Lancaster Pike, Suite 200
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.
Patents Involved
There are 7 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9051542
Compositions and methods to prevent AAV vector aggregation
|
Filed: 2010-03-19
Issued: 2015-06-09
|
Active (3.3 yrs remaining)
Expires: 2030-03-19
|
|
|
US7704721
Compositions and methods to prevent AAV vector aggregation
|
Filed: 2005-06-01
Issued: 2010-04-27
|
Expired (Term Ended)
Expires: 2025-06-01
|
|
|
US12031894
Analytical ultracentrifugation for characterization of recombinant viral particles
|
Filed: 2023-11-20
Issued: 2024-07-09
|
Active (17.0 yrs remaining)
Expires: 2043-11-20
|
|
|
US12013326
Analytical ultracentrifugation for characterization of recombinant viral particles
|
Filed: 2023-11-10
Issued: 2024-06-18
|
Active (17.0 yrs remaining)
Expires: 2043-11-10
|
|
|
US11698377
Methods for detecting AAV
|
Filed: 2017-08-14
Issued: 2023-07-11
|
Active (11.7 yrs remaining)
+359d PTA
Expires: 2038-08-08
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
52
Dispositive
3
Granted
3
Denied
0
Pending / Review
34
Motions by Category
Key Dispositive Motions & Rulings